Concepedia

Francesca Molinari

FM

38

Publications

7.7K

Citations

27

H-Index

2007

Active since

Affiliations

Istituto Cantonale di Patologia(Current)

Ospedale San Giovanni Bellinzona

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Istituti di Ricovero e Cura a Carattere Scientifico

IFOM

Francesca Molinari is an author at Istituto Cantonale di Patologia specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

2007–2022

38

Publications

38

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Wendy De Roock, Bart Claes, David Bernasconi et al. · The Lancet Oncology · 2010 · 2.1K citations

, , +5

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

, , +13

<i>PIK3CA</i> Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Andrea Sartore‐Bianchi, Miriam Martini, Francesca Molinari et al. · Cancer Research · 2009 · 735 citations

, , +17

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

Milo Frattini, Piercarlo Saletti, Elena Romagnani et al. · British Journal of Cancer · 2007 · 536 citations · Full text

<i>IDH1</i>mutations at residue p.R132 (IDH1<sup>R132</sup>) occur frequently in high-grade gliomas but not in other solid tumors

Fonnet E. Bleeker, Simona Lamba, Sieger Leenstra et al. · Human Mutation · 2009 · 366 citations · Full text

, , +19

Rows per page

1–5 of 38